Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New VivaVein Treatment for Facial Thread Veins
  • USA - English


News provided by

SkinViva

Nov 20, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Dr Tim Pearce MB ChB BSc (Hons) MRCGP
Dr Tim Pearce MB ChB BSc (Hons) MRCGP

Manchester (PRWEB UK) 20 November 2014 -- The new VivaVein treatment by SkinViva has been created to tackle some of the most common yet stubborn skin complaints. VivaVein uses clinically proven microwave technology to removal facial thread veins and spider veins.

Treatment offers instantly visible results. It is safe with no known side-effects and causes minimal discomfort, if any. What’s more, results are permanent, so in the majority of cases, thread veins don’t recur.

Post this

Issues such as broken capillaries and visible veins are rarely a medical issue, yet for the sufferer they can be a significant aesthetic concern. Networks of spider veins can lend a ‘ruddiness’ to the face which is ageing and looks unhealthy, while larger thread veins can become prominent and difficult to disguise even with heavy makeup.

VivaVein’s advanced technology allows SkinViva’s doctors to tackle facial vein issues quickly and with minimal discomfort. Using a super-fine probe, specially configured micro-waves are used to heat the vein, causing it to collapse immediately within the skin in a process known as coagulation. The destroyed vein is then naturally broken down and reabsorbed by the body.

Dr Tim Pearce MB ChB BSc (Hons) MRCGP, Skinviva’s Clinical Director, explains more:

“Many of our patients have expressed concerns about facial thread veins spoiling their complexion. We have been keen to find a solution to this problem, but the more common treatment options, such as IPL, laser or electrolysis, can be unsatisfactory for a range of reasons. In some cases, treatment is quite painful with the risk of unpleasant side-effects. In other, cases results are just not good enough.”

“VivaVein treatment is based on British technology which has a 15-year track record and excellent clinical trial data. Our doctors assessed the system very carefully. We were impressed with the results and totally confident about our choice for creating the VivaVein treatment.”

“For our patients, it is literally too good to be true. Treatment offers instantly visible results. It is safe with no known side-effects and causes minimal discomfort, if any. What’s more, results are permanent, so in the majority of cases, thread veins don’t recur.”

While many patients might see complete removal of the veins in one treatment, others might require one or two additional sessions, which are offered at a lower price than the first.

VivaVein treatment is priced at £299 for the first fifteen minute session. Depending on the severity of the problem, a course of treatments with built-in savings may be recommended.

For larger veins, such as those on the legs, VivaVein can be used in conjunction with sclerotherapy injections for a comprehensive vein removal treatment. SkinViva are launching VivaVein with an introductory £50 off first and subsequent treatments until the end of December 2014.

While tackling facial vein problems is likely to be the primary use, the VivaVein system also offers treatment for other skin blemishes; including milia (milk spots), skin tags or Campbell-de-Morgan spots (red dots or bumps). It can also be used to tackle these issues and fine thread veins on the body as well as the face.

SkinViva offer a free consultation with their experienced doctors to enable prospective patients to have a proper assessment of their skin blemishes. This will include discussion about any possible underlying causes, before the doctor provides expert advice on the most appropriate treatment for the patient’s unique needs and requirements. There is no obligation at all to proceed unless both sides are completely comfortable with the treatment plan

SkinViva was established in 2008 and have an excellent reputation for delivering excellent results and high patient satisfaction through their professional skin treatments. They are based in Manchester with their own flagship clinic is in the Castlefield area and have an extensive network of over 80 additional skin treatment clinic locations over the North West of England, including Cheshire, Lancashire and Derbyshire as well as a dedicated skin treatments training school, SkinViva Training, in 2013.

Client Liaison, SkinViva, http://www.skinviva.com/, +44 1618651141, [email protected]

Modal title

Logo
Logo
Dr Tim Pearce MB ChB BSc (Hons) MRCGP
Dr Tim Pearce MB ChB BSc (Hons) MRCGP
Manchester Clinic
Manchester Clinic
Logo Dr Tim Pearce MB ChB BSc (Hons) MRCGP Manchester Clinic

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.